Development of A Decahedral Nanoenzyme Capable of Overcoming Hypoxia to Facilitate the Iodine-125 Radiosensitization of Esophageal Cancer

Radioisotopes have long been leveraged for internal radiotherapy-mediated cancer treatment. However, such therapeutic approaches are associated with serious side effects, and their efficacy is limited by intratumoral hypoxia. Herein, we prepared a folic acid-decorated palladium decahedral platform c...

Full description

Bibliographic Details
Main Authors: Dechao Jiao, Kunpeng Wu, Kaihao Xu, Yiming Liu, Deyao Zhao, Xinwei Han, Ruitai Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2021.764531/full
_version_ 1818902180154834944
author Dechao Jiao
Kunpeng Wu
Kaihao Xu
Yiming Liu
Deyao Zhao
Xinwei Han
Ruitai Fan
author_facet Dechao Jiao
Kunpeng Wu
Kaihao Xu
Yiming Liu
Deyao Zhao
Xinwei Han
Ruitai Fan
author_sort Dechao Jiao
collection DOAJ
description Radioisotopes have long been leveraged for internal radiotherapy-mediated cancer treatment. However, such therapeutic approaches are associated with serious side effects, and their efficacy is limited by intratumoral hypoxia. Herein, we prepared a folic acid-decorated palladium decahedral platform capable of enhancing the radiotherapeutic efficacy of iodine-125 (125I) seed treatment. This decahedral nanoenzyme was able to target tumor regions and catalyze the conversion of intracellular H2O2 to O2, thereby alleviating hypoxia within the tumor microenvironment. In addition, palladium was hypoxia can be alleviated, on the other hand, palladium was able to enhance the radiotherapeutic energy deposition within tumor tissues. The results of this analysis indicated that synthesized decahedral constructs can efficiently target and modify the hypoxic tumor microenvironment while simultaneously enhancing radiation energy deposition therein. Relative to palladium nanodots, the prolonged in vivo circulation of these decahedral constructs better enabled them to facilitate sustained radiosensitization. Overall, the results of this study highlight a novel approach to improving the therapeutic utility of 125I seed interstitial implantation, thus underscoring an important direction for future clinical research.
first_indexed 2024-12-19T20:31:33Z
format Article
id doaj.art-360da2e845d6430785eedf1fb1785d73
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-12-19T20:31:33Z
publishDate 2021-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-360da2e845d6430785eedf1fb1785d732022-12-21T20:06:39ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852021-10-01910.3389/fbioe.2021.764531764531Development of A Decahedral Nanoenzyme Capable of Overcoming Hypoxia to Facilitate the Iodine-125 Radiosensitization of Esophageal CancerDechao Jiao0Kunpeng Wu1Kaihao Xu2Yiming Liu3Deyao Zhao4Xinwei Han5Ruitai Fan6Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Irradiation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Irradiation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaRadioisotopes have long been leveraged for internal radiotherapy-mediated cancer treatment. However, such therapeutic approaches are associated with serious side effects, and their efficacy is limited by intratumoral hypoxia. Herein, we prepared a folic acid-decorated palladium decahedral platform capable of enhancing the radiotherapeutic efficacy of iodine-125 (125I) seed treatment. This decahedral nanoenzyme was able to target tumor regions and catalyze the conversion of intracellular H2O2 to O2, thereby alleviating hypoxia within the tumor microenvironment. In addition, palladium was hypoxia can be alleviated, on the other hand, palladium was able to enhance the radiotherapeutic energy deposition within tumor tissues. The results of this analysis indicated that synthesized decahedral constructs can efficiently target and modify the hypoxic tumor microenvironment while simultaneously enhancing radiation energy deposition therein. Relative to palladium nanodots, the prolonged in vivo circulation of these decahedral constructs better enabled them to facilitate sustained radiosensitization. Overall, the results of this study highlight a novel approach to improving the therapeutic utility of 125I seed interstitial implantation, thus underscoring an important direction for future clinical research.https://www.frontiersin.org/articles/10.3389/fbioe.2021.764531/fullnanoenzymeradiotherapyhypoxia125 Iesophageal cancer
spellingShingle Dechao Jiao
Kunpeng Wu
Kaihao Xu
Yiming Liu
Deyao Zhao
Xinwei Han
Ruitai Fan
Development of A Decahedral Nanoenzyme Capable of Overcoming Hypoxia to Facilitate the Iodine-125 Radiosensitization of Esophageal Cancer
Frontiers in Bioengineering and Biotechnology
nanoenzyme
radiotherapy
hypoxia
125 I
esophageal cancer
title Development of A Decahedral Nanoenzyme Capable of Overcoming Hypoxia to Facilitate the Iodine-125 Radiosensitization of Esophageal Cancer
title_full Development of A Decahedral Nanoenzyme Capable of Overcoming Hypoxia to Facilitate the Iodine-125 Radiosensitization of Esophageal Cancer
title_fullStr Development of A Decahedral Nanoenzyme Capable of Overcoming Hypoxia to Facilitate the Iodine-125 Radiosensitization of Esophageal Cancer
title_full_unstemmed Development of A Decahedral Nanoenzyme Capable of Overcoming Hypoxia to Facilitate the Iodine-125 Radiosensitization of Esophageal Cancer
title_short Development of A Decahedral Nanoenzyme Capable of Overcoming Hypoxia to Facilitate the Iodine-125 Radiosensitization of Esophageal Cancer
title_sort development of a decahedral nanoenzyme capable of overcoming hypoxia to facilitate the iodine 125 radiosensitization of esophageal cancer
topic nanoenzyme
radiotherapy
hypoxia
125 I
esophageal cancer
url https://www.frontiersin.org/articles/10.3389/fbioe.2021.764531/full
work_keys_str_mv AT dechaojiao developmentofadecahedralnanoenzymecapableofovercominghypoxiatofacilitatetheiodine125radiosensitizationofesophagealcancer
AT kunpengwu developmentofadecahedralnanoenzymecapableofovercominghypoxiatofacilitatetheiodine125radiosensitizationofesophagealcancer
AT kaihaoxu developmentofadecahedralnanoenzymecapableofovercominghypoxiatofacilitatetheiodine125radiosensitizationofesophagealcancer
AT yimingliu developmentofadecahedralnanoenzymecapableofovercominghypoxiatofacilitatetheiodine125radiosensitizationofesophagealcancer
AT deyaozhao developmentofadecahedralnanoenzymecapableofovercominghypoxiatofacilitatetheiodine125radiosensitizationofesophagealcancer
AT xinweihan developmentofadecahedralnanoenzymecapableofovercominghypoxiatofacilitatetheiodine125radiosensitizationofesophagealcancer
AT ruitaifan developmentofadecahedralnanoenzymecapableofovercominghypoxiatofacilitatetheiodine125radiosensitizationofesophagealcancer